Skip to content

The Application Value of Rectal Indomethacin in Analgesia and Anti-inflammatory Before Laparoscopic Appendectomm

The Application Value of Rectal Indomethacin in Analgesia and Anti-inflammatory Before Laparoscopic Appendectomm

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200062004
Enrollment
Unknown
Registered
2022-07-19
Start date
2022-07-20
Completion date
Unknown
Last updated
2023-04-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Acute appendicitis

Interventions

Group Rectal Indomethacin: Indomethacin is administered rectally
Group Lornoxicam: Lornoxicam intramuscularly or into pots

Sponsors

Beijing Luhe Hospital, Capital Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1. 18-75 years old diagnosed with acute appendicitis; 2. Received LA; 3. Preoperative VAS score >2 points.

Exclusion criteria

Exclusion criteria: 1. Those with CONTRAINS to LA; 2. Refused or could not cooperate with the completion of this study; 3. Used other analgesic regimens before surgery; 4. Patients with any history of allergy to NSAIDs such as indomethacin and lornoxicam; 5. Patients with acute and chronic renal insufficiency, bronchial asthma, coagulation disorders, peptic ulcer diseases, and liver failure; 6. Patients who took NSAIDs or corticosteroids (due to chronic inflammatory diseases) within 48 hours; 7. Opioids or substance abusers;8. Pregnancy; 9. Receiving antidepressants 24 hours before surgery; 10. Patients with rectal, and other diseases that are not suitable for rectal administration; 11. Patients with missing clinical data.

Design outcomes

Primary

MeasureTime frame
Pain score;

Secondary

MeasureTime frame
Time for first remediation of analgesia;The amount of postoperative analgesic drugs used;Postoperative VAS is less than 2 minutes;Incidence of nausea and vomiting;Gastrointestinal recovery time (exhaust time);white blood cell count(WBC);Central granulocyte percentage(N%);c reactive protein(CRP);procalcitonin(PCT);Appendicitis Inflammatory Response(AIR);Length of hospital stay;Hospitalization costs;Unplanned readmission rates;Immune indicators;

Countries

China

Contacts

Public ContactLiu Yong

Beijing Luhe Hospital, Capital Medical University

jiankangliuyong@sina.com+86 13146306145

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 8, 2026